Tectonic Therapeutics TECX Stock Issuance Proceeds
Stock Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by Tectonic Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.
The official record: Tectonic Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tectonic Therapeutics's stock issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tectonic Therapeutics's stock issuance proceeds?
- Tectonic Therapeutics (TECX) reported stock issuance proceeds of $100K in Q1 2026.
- How has Tectonic Therapeutics's stock issuance proceeds changed year-over-year?
- Tectonic Therapeutics's stock issuance proceeds decreased by 89.7% year-over-year, from $972K to $100K.
- What is the long-term trend for Tectonic Therapeutics's stock issuance proceeds?
- Over 3 years (2021 to 2025), Tectonic Therapeutics's stock issuance proceeds has grown at a 10.2% compound annual growth rate (CAGR), from $920K to $1.23M.
- What does stock issuance proceeds mean?
- Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.